Decision Tree for Protein Biomarker Selection for Clinical Applications

Research output: Chapter in Book / Report / Conference proceedingChapterAcademicpeer-review

Abstract

Discovery of novel protein biomarkers for clinical applications is an active research field across a manifold of diseases. Despite some successes and progress, the biomarker development pipeline still frequently ends in failure. Biomarker candidates that are discovered by appropriate technologies such as unbiased mass spectrometry cannot be validated or translated to immunoassays in many cases. Selection of strong disease biomarker candidates that further constitute suitable targets for antibody binding in immunoassays is thus important to allow routine clinical use. This essential selection step can be supported and rationalized using bioinformatics tools such as protein databases. Here, we present a workflow in the form of decision trees to computationally investigate biomarker candidates and their available affinity reagents in depth. This analysis can identify the most promising biomarker candidates for assay development, while minimal time and effort are required.

Original languageEnglish
Title of host publicationTissue Proteomics
Subtitle of host publicationMethods and Protocols
EditorsTaufika Islam Williams
PublisherHumana Press
Pages355-368
Number of pages14
ISBN (Electronic)9781071642986
ISBN (Print)9781071642979, 9781071643006
DOIs
Publication statusPublished - 2025

Publication series

NameMethods in molecular biology (Clifton, N.J.)
PublisherHumana Press
Volume2884
ISSN (Print)1064-3745

Bibliographical note

Publisher Copyright:
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

  • Antibodies
  • Bioinformatics
  • Immunoassays
  • Online databases
  • Protein biomarker

Fingerprint

Dive into the research topics of 'Decision Tree for Protein Biomarker Selection for Clinical Applications'. Together they form a unique fingerprint.

Cite this